Your
CMS GUIDE
Partner for Specialized Dementia Support
Learn more
For Patients & Families
Getting Started
How It Works
Frequently Asked Questions
CMS GUIDE Program
Our Services
Cognitive Care
Alzheimer's Disease
Frontotemporal Dementia
Lewy Body Dementia
All Services...
Movement Care
Parkinson's Disease
Huntington's Disease
All Services...
Neuromuscular Care
Amyotrophic Lateral Sclerosis
Primary Lateral Sclerosis
All Services...
Mental Health Care
All Services...
Care Coordination
Insurance Management & Prior Authorization
Proactive Genetic Testing & Counseling
Clinical Trials & Investigational Therapies
For Partners
Who We Work With
Partners
Providers
Payers
GUIDE
Research
Learn more about the CMS GUIDE program
Resources
Content & Media
Our Blog
Press Releases
Movement Care
Parkinson's Disease
Huntington's Disease
All Services...
About Us
Who We Are
Our Story
Leadership Team
Our Clinicians
Company
Careers
Collaborators & Supporters
Contact Us
All Services...
Care Coordination
Insurance Management & Prior Authorization
Proactive Genetic Testing & Counseling
Clinical Trials & Investigational Therapies
Login
Book your visit
Call us to book
(855) 255-5917
Author
Peter Wallach
February 9, 2024
Neurodegenerative Care Means Cutting-Edge Treatments and Clinical Trials
By integrating emerging treatments and clinical studies into personalized care, Synapticure accelerates research and democratizes access to the latest therapies.
February 9, 2024
Enhancing ALS Care with Clene's Expanded Access Program
Synapticure's virtual platform enhances accessibility to Clene's Expanded Access Program for people living with ALS
February 9, 2024
Continuing the Fight for Improved Care and Support
Synapticure’s co-founders bring the fight for improved care to the White House
February 9, 2024
It’s A Wonderful Life: Gratitude for Friendships on our Journey
A story of friendship, overcoming adversity, building a movement and changing healthcare
February 9, 2024
Synapticure’s Co-founders Featured on CBS Sunday Morning: “Fighting the good fight against ALS”
Lee Cowan shared the personal and professional journey of Synapticure’s co-founders who are “Fighting the good fight against ALS”
February 9, 2024
How The Dementia GUIDE Program Enhances Caregiving
Synapticure will participate in a first-of-its-kind CMS program to support patients and caregivers living with dementia
February 9, 2024
EAPs Explained: What are Expanded Access Programs and How to Participate
What are EAPs? Learn about Expanded Access Programs and how to participate in them with Synapticure
February 9, 2024
ALS: The Disease that Stopped “The Iron Horse,” Lou Gehrig
On June 2nd, MLB honors Lou Gehrig to raise awareness about ALS
February 9, 2024
How we support partner clinics
Synapticure empowers physician partners by supplementing their care in ways customized to the clinic
February 9, 2024
How Peter Wallach honors his brother (and co-founder)
My name is Peter Wallach and I am the Chief Financial Officer & Co-Founder at Synapticure. After my brother was diagnosed with ALS our family founded Synapticure to help him and others.
.png)
